Related references
Note: Only part of the references are listed.Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts
Lester Tsai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease
Joseph D. Feuerstein et al.
GASTROENTEROLOGY (2021)
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
Laurent Peyrin-Biroulet et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)
Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study
Sanjay K. Murthy et al.
GUT (2020)
The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor
Hadrien Alric et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment
Vince B. C. Biemans et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Treatment Algorithms for Crohn's Disease
Michael Christian Sulz et al.
DIGESTION (2020)
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease
Amy L. Lightner et al.
DISEASES OF THE COLON & RECTUM (2020)
Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs
Ameur M. Manceur et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
P391 The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registry
M Guasch et al.
Journal of Crohns & Colitis (2018)
Surgery for Intestinal Crohn's Disease: Results of a multidisciplinary approach
Deniz Atasoy et al.
TURKISH JOURNAL OF SURGERY (2018)
Crohn Disease: Epidemiology, Diagnosis, and Management
Joseph D. Feuerstein et al.
MAYO CLINIC PROCEEDINGS (2017)
Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study
Christopher Ma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Development of the Lemann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease
Benjamin Pariente et al.
GASTROENTEROLOGY (2015)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
Alexandra D. Frolkis et al.
GASTROENTEROLOGY (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia et al.
GASTROENTEROLOGY (2010)
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease
GR Lichtenstein et al.
GASTROENTEROLOGY (2005)
Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries
GR Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease
E Louis et al.
GUT (2001)
Share Paper
